Funding News

LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future,” “FF” or the “Company”), a California-based global Embodied AI (EAI) ecosystem company, today announced that it plans to hold the Annual Meeting of Stockholders (the “Annual Meeting”) on May 22, 2026, to seek approval for proposals aimed at supporting the Company’s Global EAI strategic execution and long-term growth. The Company’s Board of Directors (the “Board”) urges all stockholders to vot...

BOSTON--(BUSINESS WIRE)--Eaton Vance Limited Duration Income Fund (NYSE: EVV), Eaton Vance Senior Floating-Rate Trust (NYSE: EFR), and Eaton Vance Senior Income Trust (NYSE: EVF) (each a “Fund,” and together, the “Funds”) announced that the Board of Trustees of each Fund has authorized each Fund to conduct a voluntary tender offer for up to 100% of its outstanding auction preferred shares (“APS”) at a price per share equal to 98% of the APS liquidation preference of $25,000 per share (or $24,50...

CUPERTINO, Calif.--(BUSINESS WIRE)--Most AI startups pitch a better model. Creao AI is pitching a better loop. The startup just closed a $10 million round led by Prosperity7 Ventures — the $3 billion diversified venturing fund of Aramco Ventures — bringing total funding to $25 million across three rounds in under a year. The bet: that the AI industry's real bottleneck isn't intelligence. It's the gap between a chatbot answering a question and an agent actually running your work while you sleep....

NEW YORK--(BUSINESS WIRE)--Sideline Group announced the close of its debut fund, Sideline Group Fund I (“Fund I”), with $155 million in committed capital to Fund I and its affiliated investment vehicles. Sideline is an investment firm that partners with culture-setting brands and experiences at the intersection of consumer, sports, and media & entertainment. Fund I is backed by a diverse group of institutional investors, including a leading US university endowment, funds of funds, and famil...

SAN FRANCISCO--(BUSINESS WIRE)--Loop, the full-stack, verticalized AI platform for logistics and supply chains, today announced it has raised a $95 million Series C led by Valor Equity Partners and the Valor Atreides AI Fund, with participation from 8VC, Founders Fund, Index Ventures, J.P. Morgan Growth Equity Partners, and Tao Capital Partners. The new funding will help Loop expand its platform across a broader set of enterprise use cases, deepen its product and engineering capabilities, and i...

NEW YORK--(BUSINESS WIRE)--Zenskar, the AI-native billing and revenue automation platform powering Zero-Touch Finance for real-world complexity, today announced a $15 million Series A led by Susquehanna Venture Capital, Bessemer Venture Partners, Shine Capital and Rho, with participation from Rocketship, J-Ventures, Future Back Ventures by Bain & Company, and Converge. The funding will expand Zenskar's agentic capabilities. Zenskar was built to solve revenue automation for the complex prici...

DUBLIN--(BUSINESS WIRE)--Avolon Holdings Limited (‘Avolon’), a leading global aviation finance company, announces that it has raised a new dual tranche US$455 million unsecured revolving credit facility (the ‘Facility’) with a syndicate of five banks based primarily in the Middle East. The transaction further diversifies Avolon’s sources of capital, accessing new liquidity pools with significant appetite for high quality lending opportunities in the aviation sector. The facility, which comprise...

SAN FRANCISCO--(BUSINESS WIRE)--Most doctors went into medicine to help people. But the system they entered wasn't built for that — high-volume visits, fragmented records, treat the symptom and move on. Over time, a growing number of physicians have gotten disillusioned and started asking a harder question: what if I could practice medicine the way I originally intended? That question is driving a movement. Functional, integrative, and longevity medicine is one of the fastest-growing segments o...

CANTON, Mass.--(BUSINESS WIRE)--Orthogon Therapeutics today announced the closing of a follow-on $11 million financing, bringing its total capital raised to $36 million. This financing supports the continued advancement of its first-in-class drug against BK polyomavirus. BK virus infections are a major cause of complications in transplant patients, with no approved treatments. The company is pioneering an oral therapy that addresses the full spectrum of BK infection, from early reactivation thr...

DOWNERS GROVE, Ill.--(BUSINESS WIRE)--InvenTrust Properties Corp. (“InvenTrust” or the “Company”) (NYSE: IVT) today announced that it has signed a definitive note purchase agreement providing for a private placement of $250 million senior unsecured notes of which $50 million are designated as 5.09% Series A senior notes due June 29, 2029, $100 million are designated as 5.32% Series B senior notes due June 29, 2031, and $100 million are designated as 5.60% Series C senior notes due June 29, 2033...